# Hepatitis B Vaccine for Non-responders

> **NCT03415672** · PHASE2 · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 133 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** HBVaxPro
- **BIOLOGICAL:** HBAI20

## Key facts

- **NCT ID:** NCT03415672
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-11
- **Primary completion:** 2019-01-09
- **Final completion:** 2019-01-09
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2019-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415672, "Hepatitis B Vaccine for Non-responders". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03415672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*